Minodronic Acid is a potent third-generation bisphosphonate indicated for the treatment of osteoporosis to prevent bone loss and associated fractures. By targeting farnesyl pyrophosphate synthase, this… Read more
![Chemical structure of (1-Hydroxy-2-(imidazo[1,2-a]pyridin-2-yl)ethane-1,1-diyl)bis(phosphonic acid)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F127657-45-8-1-Hydroxy-2-imidazo12-apyridin-2-ylethane-11-diylbisphosphonic-acid.png&w=3840&q=75)
![Chemical structure of (2,5-Dihydroxy-3,6-bis(imidazo[1,2-a]pyridin-3-ylmethyl)-2,5-dioxido-1,4,2,5-dioxadiphosphinane-3,6-diyl)bis(phosphonic acid)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2303523-19-3-25-Dihydroxy-36-bisimidazo12-apyridin-3-ylmethyl-25-dioxido-1425-dioxadiphosphinane-36-diylbisphosphonic-acid.png&w=3840&q=75)
![Chemical structure of (2-(Imidazo[1,2-a]pyridin-3-yl)-1-(2-(imidazo[1,2-a]pyridin-3-yl)acetoxy)ethane-1,1-diyl)bis(phosphonic acid)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-Imidazo12-apyridin-3-yl-1-2-imidazo12-apyridin-3-ylacetoxyethane-11-diylbisphosphonic-acid.png&w=3840&q=75)
![Chemical structure of (2-(Imidazo[1,2-a]pyridin-3-yl)acetyl)phosphonic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-Imidazo12-apyridin-3-ylacetylphosphonic-Acid.png&w=3840&q=75)







![Chemical structure of Ethyl 2-(imidazo[1,2-a]pyridin-2-yl)acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F21755-34-0-Ethyl-2-imidazo12-apyridin-2-ylacetate.png&w=3840&q=75)
![Chemical structure of Ethyl 2-(imidazo[1,2-a]pyridin-3-yl)acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F101820-69-3-Ethyl-2-imidazo12-apyridin-3-ylacetate.png&w=3840&q=75)


Minodronic Acid is a potent third-generation bisphosphonate indicated for the treatment of osteoporosis to prevent bone loss and associated fractures. By targeting farnesyl pyrophosphate synthase, this antiresorptive agent inhibits osteoclast-mediated bone resorption, effectively reducing osteoclast activity and formation. Laboratories require high-quality reference standards for this compound and its related derivatives to ensure regulatory compliance and therapeutic efficacy. This category contains a comprehensive selection of Minodronic Acid impurities, metabolites, and stable isotope labelled compounds, which are essential tools for impurity profiling and rigorous quality control. These analytical standards facilitate accurate method validation and the reliable identification of degradation products or synthetic by-products in pharmaceutical testing. By utilizing these precise materials, researchers and quality control scientists can maintain the standard of analytical rigor required for the accurate assessment of the active pharmaceutical ingredient.